6-153024447-T-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_012419.5(RGS17):c.259A>G(p.Lys87Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000413 in 1,614,204 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012419.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGS17 | NM_012419.5 | c.259A>G | p.Lys87Glu | missense_variant | Exon 4 of 5 | ENST00000206262.2 | NP_036551.3 | |
RGS17 | XM_047418634.1 | c.304A>G | p.Lys102Glu | missense_variant | Exon 4 of 5 | XP_047274590.1 | ||
RGS17 | XM_047418635.1 | c.292A>G | p.Lys98Glu | missense_variant | Exon 4 of 5 | XP_047274591.1 | ||
RGS17 | XM_047418636.1 | c.259A>G | p.Lys87Glu | missense_variant | Exon 4 of 5 | XP_047274592.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152232Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000314 AC: 79AN: 251342 AF XY: 0.000294 show subpopulations
GnomAD4 exome AF: 0.000430 AC: 628AN: 1461854Hom.: 1 Cov.: 32 AF XY: 0.000477 AC XY: 347AN XY: 727234 show subpopulations
GnomAD4 genome AF: 0.000256 AC: 39AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74504 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.259A>G (p.K87E) alteration is located in exon 4 (coding exon 3) of the RGS17 gene. This alteration results from a A to G substitution at nucleotide position 259, causing the lysine (K) at amino acid position 87 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at